More Globe Newswire

View Older Stories View Newer Stories

Dec 10, 2023 08:33PM Milestone Scientific Inc. Announces Pricing of $3.0 Million Public Offering of Common Stock
Dec 10, 2023 08:03PM ROSEN, A LEADING AND TOP RANKED LAW FIRM, Encourages Roblox Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – RBLX
Dec 10, 2023 08:00PM InfiRay Plans to Detail the World's Smallest Thermal Camera P2 Pro at CES 2024
Dec 10, 2023 08:00PM InfiRay Plans to Detail the World's Smallest Thermal Camera P2 Pro at CES 2024
Dec 10, 2023 07:54PM ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages National Instruments Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NATI
Dec 10, 2023 07:30PM Press Release: Sarclisa® (isatuximab) plus KRd significantly improved rate of minimal residual disease negativity in transplant-eligible patients with newly diagnosed multiple myeloma versus KRd alon
Dec 10, 2023 07:30PM Latest Odronextamab Data in Relapsed/Refractory Follicular Lymphoma Showed Compelling Responses and Overall Maintenance of Patient-Reported Outcomes
Dec 10, 2023 07:30PM Novartis presents new 48-week results from Phase III APPLY-PNH trial showing sustained efficacy and long-term safety of Fabhalta® (iptacopan) in adults with paroxysmal nocturnal hemoglobinuria (PNH)
Dec 10, 2023 05:58PM ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages Paycom Software, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action First Filed by the Firm – PAYC
Dec 10, 2023 05:10PM ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages SCYNEXIS, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – SCYX
Dec 10, 2023 04:32PM MVST INVESTOR NOTICE: Robbins Geller Rudman & Dowd LLP Announces that Microvast Holdings, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
Dec 10, 2023 04:24PM ONE Announces Manufacturing Veteran and Founding Board Member, Paul Humphries as New CEO
Dec 10, 2023 02:21PM Change in the Management Board of AS PRFoods
Dec 10, 2023 01:45PM ROSEN, A LONGSTANDING AND TRUSTED FIRM, Encourages SunPower Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – SPWR
Dec 10, 2023 12:30PM Updated Odronextamab Data from Relapsed/Refractory Diffuse Large B-cell Lymphoma Pivotal Trial Showed Deep and Durable Responses and the Potential of ctDNA To Predict Long-term Outcomes
Dec 10, 2023 12:05PM Centessa Pharmaceuticals Announces New Data from an Additional 52-Weeks of Continuous Treatment from Third Year (Part 5) of Ongoing Phase 2a Study of SerpinPC for the Treatment of Hemophilia
Dec 10, 2023 12:00PM Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting
Dec 10, 2023 12:00PM Vincerx Pharma Presents Preclinical VIP943 and VIP924 Posters at ASH 2023
Dec 10, 2023 12:00PM Molecular Partners Presents Positive Initial Data from First Four Dosing Cohorts of Ongoing Phase 1/2a Trial of MP0533 for Patients with Relapsed/Refractory AML and AML/MDS at ASH Annual Meeting
Dec 10, 2023 11:00AM Jasper Therapeutics Presents Positive Final Results from Phase 1 Study of Briquilimab in Patients with AML or MDS Undergoing Hematopoietic Cell Transplant in Oral Presentation at ASH 2023
Dec 10, 2023 10:00AM Survey Reveals Over Half of U.S.Consumers Hold Positive Views on AI in Marketing
Dec 10, 2023 08:19AM ROSEN, TRUSTED INVESTOR COUNSEL, Encourages The Beauty Health Company Investors to Secure Counsel Before Important Deadline in Securities Class Action – SKIN
Dec 10, 2023 08:09AM Flash News: OKX to change funding fee collection mechanism
Dec 10, 2023 05:53AM The UAE Pavilion Features the Launch of the Data-Driven Earth Platform on Nature, Land and Oceans Day at copper 28
Dec 10, 2023 04:02AM Flash News: OKX Wallet Partners with ETHPLUS (ETH+), Giving Users an APR Boost of Up to 20% on Staked ETH and ETH+
Dec 9, 2023 08:31PM Nkarta Presents NKX101 Clinical Data at the 2023 American Society of Hematology Annual Meeting & Exposition
Dec 9, 2023 08:30PM Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2023
Dec 9, 2023 07:45PM ROSEN, SKILLED INVESTOR COUNSEL, Encourages Li-Cycle Holdings Corp. Investors to Secure Counsel Before Important Deadline in Securities Class Action – LICY
Dec 9, 2023 07:00PM Agios Presents Positive Results from Phase 2 Portion of the RISE UP Pivotal Study in Sickle Cell Disease at 65th ASH Annual Meeting and Exposition
Dec 9, 2023 06:30PM Aptose Tuspetinib Clinical Data Featured in Oral Presentation at the 2023 ASH Annual Meeting
Dec 9, 2023 05:30PM Biomea Fusion Announces Near Doubling the Percentage of Patients with Durable HbA1c Reduction in the 200 mg Dose Cohorts
Dec 9, 2023 05:21PM ROSEN, LEADING INVESTOR COUNSEL, Encourages Expensify, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action – EXFY
Dec 9, 2023 05:02PM FibroGen Presents Data from Phase 3 MATTERHORN Trial of Roxadustat in Patients with Anemia of Lower Risk Transfusion-Dependent Myelodysplastic Syndromes at American Society of Hematology Annual Meetin
Dec 9, 2023 03:04PM FTCH INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Farfetch Limited Investors with Substantial Losses Have Opportunity to Lead Case
Dec 9, 2023 01:51PM KRF Capital’s, inaugural K Energy Growth Equity Fund launches with investment in United States Sail GP Team
Dec 9, 2023 01:30PM Cogent Biosciences Announces Positive Initial Data from Phase 2 SUMMIT Trial Evaluating Bezuclastinib in Patients with Nonadvanced Systemic Mastocytosis (NonAdvSM)
Dec 9, 2023 01:15PM FSR INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Announces that Fisker Inc. Investors with Substantial Losses Have Opportunity to Lead Case
Dec 9, 2023 12:12PM Managers’ transactions
Dec 9, 2023 12:00PM X4 Pharmaceuticals Announces Presentation of Additional Data from Mavorixafor Phase 2 Trial in Chronic Neutropenia at ASH 2023
Dec 9, 2023 12:00PM Corvus Pharmaceuticals Presents New Interim Soquelitinib Data from its Phase 1/1b T Cell Lymphoma Trial
Dec 9, 2023 12:00PM Allogene Therapeutics Presents Comprehensive Safety Data of Proprietary Lymphodepletion Agent ALLO-647 at the 65th Annual Meeting of the American Society of Hematology
Dec 9, 2023 12:00PM TScan Therapeutics Presents Initial Phase 1 Clinical Results on TSC-100 and TSC-101 at the 65th American Society of Hematology Annual Meeting and Exposition
Dec 9, 2023 12:00PM Century Therapeutics Presents Initial Data from CNTY-101 Phase 1 ELiPSE-1 Trial Supporting the Potential for a Multi-Dosing Strategy for CAR iNK Enabled by Allo-Evasion™ Edits
Dec 9, 2023 12:00PM New Pivotal Data for Bispecific Antibody Epcoritamab (DuoBody® CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma (FL)
Dec 9, 2023 12:00PM Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101
Dec 9, 2023 11:30AM New data reinforce the benefit of early preventative treatment with Roche’s Hemlibra for babies with severe haemophilia A
Dec 9, 2023 10:00AM Bulletin from Annual General Meeting in SkiStar AB
Dec 9, 2023 09:53AM NKLA FINAL DEADLINE ALERT: ROSEN, LEADING INVESTOR COUNSEL, Encourages Nikola Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action – NKLA
Dec 9, 2023 08:34AM Flash News: OKX Wallet Now Integrated with NAVI and Offers Extra Yield For a Limited Time
Dec 9, 2023 08:30AM Adaptive Biotechnologies Announces New Data Highlighting the Clinical Relevance of MRD Testing with clonoSEQ® in Patients with Blood Cancers at the 65th ASH Annual Meeting
View Newer Stories View Older Stories